Haemochromatosis is a hereditary condition, common in Ireland, characterised by an over-absorption of iron from the gastrointestinal tract. Excess iron accumulates in organs including the liver, pancreas and heart, causing damage. I am informed that Ireland has been confirmed as having the highest rate of haemochromatosis worldwide. I am advised by the HSE that the Irish Haemochromatosis Association receives €55,000 in funding from the Health Service Executive each year to support engagement, raise awareness, support patients, their families and the medical community and raise awareness of haemochromatosis. The association’s initiatives include World Haemochromatosis Awareness Week, taking place from 1 to 7 June every year, and the GP practice nurse training and education programme. The diagnosis, treatment and management of patients living with the condition is guided by the hereditary haemochromatosis model of care, developed by the hereditary haemochromatosis working group, and the guidance document of the Irish College of General Practitioners, Hereditary Haemochromatosis: Diagnosis and Management from a GP Perspective. I understand that the condition can be treated very effectively by a process called venesection or therapeutic phlebotomy, which involves the patient having their blood taken. This can happen in acute hospitals or GP surgeries or at an Irish Blood Transfusion Service, IBTS, facility. It is extraordinary that Ireland has the highest rate of this condition worldwide and we need to do more to drive awareness of it.